Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 236

1.

Are current standards of reporting quality for clinical trials sufficient in addressing important sources of bias?

Mills EJ, Ayers D, Chou R, Thorlund K.

Contemp Clin Trials. 2015 Jul 29. pii: S1551-7144(15)30056-2. doi: 10.1016/j.cct.2015.07.019. [Epub ahead of print]

PMID:
26232560
2.

Lack of Effectiveness of Antiretroviral Therapy in Preventing HIV Infection in Serodiscordant Couples in Uganda: An Observational Study.

Birungi J, Min JE, Muldoon KA, Kaleebu P, King R, Khanakwa S, Nyonyintono M, Chen Y, Mills EJ, Lyagoba F, Ragonnet-Cronin M, Wangisi J, Lourenco L, Moore DM.

PLoS One. 2015 Jul 14;10(7):e0132182. doi: 10.1371/journal.pone.0132182. eCollection 2015.

3.

Understanding the roles of faith-based health-care providers in Africa: review of the evidence with a focus on magnitude, reach, cost, and satisfaction.

Olivier J, Tsimpo C, Gemignani R, Shojo M, Coulombe H, Dimmock F, Nguyen MC, Hines H, Mills EJ, Dieleman JL, Haakenstad A, Wodon Q.

Lancet. 2015 Jul 3. pii: S0140-6736(15)60251-3. doi: 10.1016/S0140-6736(15)60251-3. [Epub ahead of print] Review.

PMID:
26159398
4.

Controversies in faith and health care.

Tomkins A, Duff J, Fitzgibbon A, Karam A, Mills EJ, Munnings K, Smith S, Seshadri SR, Steinberg A, Vitillo R, Yugi P.

Lancet. 2015 Jul 3. pii: S0140-6736(15)60252-5. doi: 10.1016/S0140-6736(15)60252-5. [Epub ahead of print] Review.

PMID:
26159392
5.

Combination Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Whom, When, and Where?

Siedner MJ, Campbell JI, Kanters S, Bennett JE, Thorlund K, Tsai AC, Mills EJ.

Open Forum Infect Dis. 2015 May 13;2(2):ofv071. doi: 10.1093/ofid/ofv071. eCollection 2015 Apr. No abstract available.

6.
7.

Comparative effectiveness of induction therapy for human immunodeficiency virus-associated cryptococcal meningitis: a network meta-analysis.

Campbell JI, Kanters S, Bennett JE, Thorlund K, Tsai AC, Mills EJ, Siedner MJ.

Open Forum Infect Dis. 2015 Feb 26;2(1):ofv010. doi: 10.1093/ofid/ofv010. eCollection 2015 Jan.

8.

A knowledge translation intervention to improve tuberculosis care and outcomes in Malawi: a pragmatic cluster randomized controlled trial.

Puchalski Ritchie LM, Schull MJ, Martiniuk AL, Barnsley J, Arenovich T, van Lettow M, Chan AK, Mills EJ, Makwakwa A, Zwarenstein M.

Implement Sci. 2015 Mar 28;10:38. doi: 10.1186/s13012-015-0228-y.

9.

Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs.

Thorlund K, Druyts E, Toor K, Mills EJ.

Expert Rev Gastroenterol Hepatol. 2015 May;9(5):693-700. doi: 10.1586/17474124.2015.1024657. Epub 2015 Mar 12.

PMID:
25763862
10.

Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study.

Nsanzimana S, Remera E, Kanters S, Chan K, Forrest JI, Ford N, Condo J, Binagwaho A, Mills EJ.

Lancet Glob Health. 2015 Mar;3(3):e169-77. doi: 10.1016/S2214-109X(14)70364-X.

11.

Ethical testing of experimental Ebola treatments.

Kanters S, Thorlund K, Mills EJ.

JAMA. 2015 Jan 27;313(4):421-2. doi: 10.1001/jama.2014.17259. No abstract available.

PMID:
25626046
12.

Heterogeneity in meta-analysis of FDG-PET studies to diagnose lung cancer.

Mills EJ, Jansen JP, Kanters S.

JAMA. 2015 Jan 27;313(4):419. doi: 10.1001/jama.2014.16482. No abstract available.

PMID:
25626041
13.

Completeness of main outcomes across randomized trials in entire discipline: survey of chronic lung disease outcomes in preterm infants.

Ioannidis JP, Horbar JD, Ovelman CM, Brosseau Y, Thorlund K, Buus-Frank ME, Mills EJ, Soll RF.

BMJ. 2015 Jan 26;350:h72. doi: 10.1136/bmj.h72.

14.

How do you circumcise a nation? The Rwandan case study.

Mutabazi V, Forrest JI, Ford N, Mills EJ.

BMC Med. 2014 Oct 6;12:184. doi: 10.1186/s12916-014-0184-4.

15.

Incorporating alternative design clinical trials in network meta-analyses.

Thorlund K, Druyts E, Toor K, Jansen JP, Mills EJ.

Clin Epidemiol. 2014 Dec 23;7:29-35. doi: 10.2147/CLEP.S70853. eCollection 2015.

16.

Association between antiretroviral therapy adherence and employment status: systematic review and meta-analysis.

Nachega JB, Uthman OA, Peltzer K, Richardson LA, Mills EJ, Amekudzi K, Ou├ędraogo A.

Bull World Health Organ. 2015 Jan 1;93(1):29-41. doi: 10.2471/BLT.14.138149. Epub 2014 Oct 30.

17.

Editorial commentary: immunodeficiency at start of antiretroviral therapy: the persistent problem of late presentation to care.

Ford N, Mills EJ, Egger M.

Clin Infect Dis. 2015 Apr 1;60(7):1128-30. doi: 10.1093/cid/ciu1138. Epub 2014 Dec 16. No abstract available.

18.

Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysis.

Ford N, Irvine C, Shubber Z, Baggaley R, Beanland R, Vitoria M, Doherty M, Mills EJ, Calmy A.

AIDS. 2014 Nov 28;28(18):2721-7. doi: 10.1097/QAD.0000000000000505. Review.

PMID:
25493598
19.

Building clinical trial priorities at the University of Rwanda.

Condo J, Kateera B, Mutimura E, Birungi F, Ndagijimana A, Jansen S, Kamwesiga J, Forrest JI, Mills EJ, Binagwaho A.

Trials. 2014 Nov 27;15:467. doi: 10.1186/1745-6215-15-467.

20.

Editorial commentary: Comparative efficacy of lamivudine and emtricitabine: comparing the results of randomized trials and cohorts.

Ford N, Hill A, Vitoria M, Mills EJ.

Clin Infect Dis. 2015 Jan 1;60(1):154-6. doi: 10.1093/cid/ciu767. Epub 2014 Oct 1. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk